These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2794666)
21. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia]. Ishige K; Takagi T; Oguro M Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925 [TBL] [Abstract][Full Text] [Related]
22. A rare atypical myeloproliferative-disorder-like hemopathy with marked dysplasia, peripheral dominant myeloblast proliferation and extramedullary hematopoiesis was converted into typical acute myeloid leukemia with an interval of complete hematological remission. Hagiwara S; Yuo A; Miwa A; Takezako N; Hirano N; Togawa A Int J Hematol; 1998 Jun; 67(4):411-6. PubMed ID: 9695415 [TBL] [Abstract][Full Text] [Related]
23. [An unusual way of manifesting acute granulocytic leukemia: granulocytic sarcoma of the breast. Apropos of a case with trisomy 22]. Turpin F; Trassard M; Bourguignat A; Floiras JL; Le Doussal V; Eydoux P Nouv Rev Fr Hematol (1978); 1986; 28(2):91-6. PubMed ID: 3461426 [TBL] [Abstract][Full Text] [Related]
24. [BH-AC.AMP protocol in the treatment of refractory childhood acute leukemia]. Nakadate H; Hatayama Y; Hatae Y; Takeda T Gan To Kagaku Ryoho; 1988 Oct; 15(10):2907-10. PubMed ID: 3178240 [TBL] [Abstract][Full Text] [Related]
25. [Treatment of acute non-lymphocytic leukemia with concurrent administration of N4-behenoyl-beta-D-arabinofuranosylcytosine, aclacinomycin A, 6-mercaptopurine and prednisolone; a pilot study (author's transl)]. Hirano M; Morishita Y; Ino T; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Saito M Rinsho Ketsueki; 1981 Mar; 22(3):299-305. PubMed ID: 6944508 [No Abstract] [Full Text] [Related]
26. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group. Kobayashi T; Miyawaki S; Tanimoto M; Kuriyama K; Murakami H; Yoshida M; Minami S; Minato K; Tsubaki K; Ohmoto E; Oh H; Jinnai I; Sakamaki H; Hiraoka A; Kanamaru A; Takahashi I; Saito K; Naoe T; Yamada O; Asou N; Kageyama S; Emi N; Matsuoka A; Tomonaga M; Ohno R J Clin Oncol; 1996 Jan; 14(1):204-13. PubMed ID: 8558199 [TBL] [Abstract][Full Text] [Related]
29. [A case of acute nonlymphocytic leukemia with leukemic cell infiltration to the uterus followed by bone marrow relapse]. Shiga Y; Shichishima T; Aikawa K; Gotoh J; Furukawa T; Yamagiwa A; Ishibashi T; Maruyama Y Rinsho Ketsueki; 1994 May; 35(5):501-5. PubMed ID: 8028198 [TBL] [Abstract][Full Text] [Related]
30. Curative effect of harringtonine semisynthetic harringtonine and HOAP on nonlymphocytic leukemias. Analysis of 304 cases. Zhang ZY; Hou CH; Zhu YF; You XY; Li JL; Fu Z Chin Med J (Engl); 1987 Jul; 100(7):565-8. PubMed ID: 3123163 [No Abstract] [Full Text] [Related]
31. Increasing aclarubicin dose in low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) is efficacious as salvage chemotherapy for relapsed/refractory mixed-phenotype acute leukemia. Liu L; Qu Q; Jiao W; Zhang Y; Li X; Ding C; Wu D Leuk Res; 2015 Aug; 39(8):805-11. PubMed ID: 26021434 [TBL] [Abstract][Full Text] [Related]
35. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia. AML-87 Study of the Japan Adult Leukemia Study Group. Ohno R; Kobayashi T; Tanimoto M; Hiraoka A; Imai K; Asou N; Tomonaga M; Tsubaki K; Takahashi I; Kodera Y Cancer; 1993 Jun; 71(12):3888-95. PubMed ID: 8508355 [TBL] [Abstract][Full Text] [Related]
36. Isolated central nervous system granulocytic sarcoma and meningeal myeloid leukemia: successful treatment without radiotherapy. Stepensky P; Revel-Vilk S; Yehuda-Gafni O; Mali B; Resnick IB; Weintraub M Isr Med Assoc J; 2009 Sep; 11(9):569-70. PubMed ID: 19960855 [No Abstract] [Full Text] [Related]
37. Aclarubicin and low-dose Cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome: a multicenter study of 112 Chinese patients. Li JM; Shen Y; Wu DP; Liang H; Jin J; Chen FY; Song YP; Song EY; Qiu XF; Hou M; Qiu ZC; Shen ZX Int J Hematol; 2005 Jul; 82(1):48-54. PubMed ID: 16105759 [TBL] [Abstract][Full Text] [Related]
38. [Treatment of adult acute promyelocytic leukemia during the period of 1974-1982]. Kawashima K; Nagura E; Kato Y; Suzuki H; Morishima Y; Ogura M; Watanabe E; Kodera Y; Ohno R; Sugihara T Rinsho Ketsueki; 1984 Feb; 25(2):121-8. PubMed ID: 6590879 [No Abstract] [Full Text] [Related]
39. [Individualized chemotherapy of adult acute nonlymphocytic leukemia]. Uzuka Y; Saito Y Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1473-80. PubMed ID: 2389943 [TBL] [Abstract][Full Text] [Related]
40. [Aclarubicin-related pancreatitis in a child with AML]. Adachi S; Akiyama Y; Takimoto T; Tanizawa A; Kiriyama Y; Kubota Y; Mikawa H Rinsho Ketsueki; 1988 Mar; 29(3):385-8. PubMed ID: 3165144 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]